LYC-55716, a First-in-class RORγ Agonist: Rationale and Preclinical Data to Support Clinical Combinations with Established Immunotherapies
Clinical research（2018）
Key words
Regulatory T Cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined